# Irreversible Electroporation Versus Standard Medication for Benign Prostatic Obstruction

> **NCT03448510** · PHASE2 · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Lower Urinary Tract Symptoms

## Interventions

- **DEVICE:** Irreversible electroporation
- **DRUG:** Standard Medication

## Key facts

- **NCT ID:** NCT03448510
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-01
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-05-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03448510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03448510, "Irreversible Electroporation Versus Standard Medication for Benign Prostatic Obstruction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03448510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*